Thomas J. Rimele - Concepedia

Author

Thomas J. Rimele

Research Triangle Park Foundation

Also Known As

T J Rimele, T. J. RIMELE, T. J. Rimele, T. Rimele, T.J. Rimele, Thomas J Rimele, Thomas J. Rimele, Thomas Rimele

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation Princeton University The Ohio State University GlaxoSmithKline (United States)Mayo Clinic in Arizona

About

Thomas J. Rimele is an author at Research Triangle Park Foundation specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	813
2	Biochemistry	9	9	331
3	Natural Sciences	4	4	146
4	Anesthesia	2	2	132
5	Public Health	1	1	10

Thomas J. Rimele

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Respiratory epithelium inhibits bronchial smooth muscle tone Nicholas A. Flavahan, L L Aarhus, Thomas J. Rimele, Journal of Applied Physiology	1985	386
BMY 7378 is a selective antagonist of the D subtype of α1-adrenoceptors Aaron S. Goetz, Holly K. King, Stuart D.C. Ward, European Journal of Pharmacology D SubtypeMolecular PharmacologyAdrenal GlandMedicinePhysiology	1995	302
Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor. Thomas J. Rimele, Robert J. Sturm, L.M. Adams, Journal of Pharmacology and Experimental Therapeutics	1988	163
Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120) Steven M. Sparks, Grace Chen, Jon L. Collins, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyLipid SynthesisBiochemistryMedicineMechanism Of Action	2014	102
Characterization of postjunctional alpha-1 and alpha-2 adrenoceptors activated by exogenous or nerve-released norepinephrine in the canine saphenous vein. Nicholas A. Flavahan, Thomas J. Rimele, John P. Cooke, Journal of Pharmacology and Experimental Therapeutics	1984	101
Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity. 1. Optimization of the Agonist “Trigger” Christopher Aquino, Duncan Armour, Judd Berman, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryGlaxo Registry FileFunctional SelectivityGastrointestinal Pharmacology	1996	101
Studies on rat intestinal epithelial cell receptors for serotonin and opiates. Timothy S. Gaginella, Thomas J. Rimele, Mateusz S. Wietecha The Journal of Physiology	1983	86
Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype. D L Saussy, Aaron S. Goetz, Kennedy L. Queen, Journal of Pharmacology and Experimental Therapeutics	1996	78
Discovery of 3-Aryl-4-isoxazolecarboxamides as TGR5 Receptor Agonists Karen A. Evans, Brian Budzik, Sean Ross, Journal of Medicinal Chemistry Medicinal ChemistryBiochemistryTgr5 Receptor AgonistsNatural SciencesMedicine	2009	74
Evidence for muscarinic receptors on rat colonic epithelial cells: binding of [3H]quinuclidinyl benzilate. Thomas J. Rimele, M. Sue O’Dorisio, Timothy S. Gaginella Journal of Pharmacology and Experimental Therapeutics	1981	60

Page 1